Volume 7; Issue 2

Cardiovascular Toxicology

Volume 7; Issue 2

1

Molecular and cellular mechanisms of anthracycline cardiotoxicity

Billy Chen, Xuyang Peng, Laura Pentassuglia, Chee Chew Lim, Douglas B. Sawyer

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 227 KB

english, 2007

2

Anthracycline cardiotoxicity in long-term survivors of childhood cancer

Rebecca E. Scully, Steven E. Lipshultz

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 194 KB

english, 2007

3

Antioxidant defense against anthracycline cardiotoxicity by metallothionein

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 161 KB

english, 2007

4

Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis

Kendall B. Wallace

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 192 KB

english, 2007

5

Role of mtDNA lesions in anthracycline cardiotoxicity

Dirk Lebrecht, Ulrich A. Walker

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 260 KB

english, 2007

6

Ongoing phase I and II studies of novel anthracyclines

Cristiana Sessa, Olga Valota, Cristina Geroni

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 153 KB

english, 2007

7

An introduction to the metabolic determinants of anthracycline cardiotoxicity

Pierantonio Menna, Stefania Recalcati, Gaetano Cairo, Giorgio Minotti

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 240 KB

english, 2007

8

Anthracycline-induced phospholipase A2inhibition

Luther Swift, Jane McHowat, Narine Sarvazyan

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 340 KB

english, 2007

9

Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes

Luca Gianni, Emanuela Salvatorelli, Giorgio Minotti

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 199 KB

english, 2007

10

Cardiac safety of liposomal anthracyclines

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 105 KB

english, 2007

11

Role of anthracyclines in the era of targeted therapy

Hernán Cortés-Funes, Cyntia Coronado

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 168 KB

english, 2007

12

Pathophysiology and diagnosis of cancer drug induced cardiomyopathy

Christian Zuppinger, Francesco Timolati, Thomas M. Suter

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 141 KB

english, 2007

13

The anthracyclines: When good things go bad

Giorgio Minotti, Narine Sarvazyan

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 127 KB

english, 2007

14

Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials

Aalt Bast, Guido R. M. M. Haenen, Anna M. E. Bruynzeel, Wim J. F. Van der Vijgh

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 228 KB

english, 2007

15

Novel antioxidants in anthracycline cardiotoxicity

Kálmán Hideg, Tamás Kálai

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 316 KB

english, 2007

16

New iron chelators in anthracycline-induced cardiotoxicity

Helena Kaiserová, Tomáš Šimůnek, Martin Štěrba, Gertjan J. M. den Hartog, Ladislava Schröterová, Olga Popelová, Vladimír Geršl, Eva Kvasničková, Aalt Bast

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 248 KB

english, 2007

17

Other uses of dexrazoxane: savene, the first proven antidote against anthracycline extravasation injuries

Seppo W. Langer, Peter Buhl Jensen, Maxwell Sehested

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 107 KB

english, 2007

18

Long-term and short-term models for studying anthracycline cardiotoxicity and protectors

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 199 KB

english, 2007

19

Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?

Brian B. Hasinoff, Eugene H. Herman

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 212 KB

english, 2007

20

Genotyping the risk of anthracycline-induced cardiotoxicity

Shiwei Deng, Leszek Wojnowski

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 150 KB

english, 2007

21

Iron signaling and oxidant damage

Balaraman Kalyanaraman

Journal:

Cardiovascular Toxicology

Year:

2007

Language:

english

File:

PDF, 144 KB

english, 2007